annb0t
Top 20
Clinuvel Pharmaceuticals Limited (ASX:CUV) shareholders might understandably be very concerned that the share price has dropped 35% in the last quarter. But that doesn't change the fact that the returns over the last five years have been very strong. We think most investors would be happy with the 138% return, over that period. So while it's never fun to see a share price fall, it's important to look at a longer time horizon. The more important question is whether the stock is too cheap or too e...
>>> Read more: Clinuvel Pharmaceuticals' (ASX:CUV) investors will be pleased with their solid 139% return over the last five years
>>> Read more: Clinuvel Pharmaceuticals' (ASX:CUV) investors will be pleased with their solid 139% return over the last five years
